Proxy Advisor Glass Lewis Recommends Penwest Shareholders Vote "FOR" the Company's Three Director Slate at June 22 Annual Meeting
07. Juni 2010 16:43 ET
|
Penwest Pharmaceuticals Co.
PATTERSON, N.Y., June 7, 2010 (GLOBE NEWSWIRE) -- Penwest Pharmaceuticals Co. (Nasdaq:PPCO) today announced that Glass Lewis & Co. LLC, a leading independent governance analysis and proxy voting...
Penwest Urges Shareholders to Reject Tang-Edelman Gold Card Slate Vote "For" Three Current Directors on the White Card
02. Juni 2010 08:30 ET
|
Penwest Pharmaceuticals Co.
Company has Created Shareholder Value, While Election of Dissident Slate Could
Disrupt Progress
Control of the Board and Company are at Stake
PATTERSON, N.Y., June 2, 2010 (GLOBE NEWSWIRE) --...
Penwest Urges Shareholders to Vote "For" Three Current Directors and Reject Tang/Edelman Slate
17. Mai 2010 08:27 ET
|
Penwest Pharmaceuticals Co.
Company Has Created Shareholder Value by Executing Focused Business Plan
Win by Tang/Edelman Would Give Dissidents Board Control
PATTERSON, N.Y., May 17, 2010 (GLOBE NEWSWIRE) -- Penwest...
Penwest Reports First Quarter 2010 Financial Results
03. Mai 2010 08:30 ET
|
Penwest Pharmaceuticals Co.
Posts Third Consecutive Profitable Quarter
Opana ER Royalty From Endo Now Being Paid at Full Rate
PATTERSON, N.Y., May 3, 2010 (GLOBE NEWSWIRE) -- Penwest Pharmaceuticals Co. (Nasdaq:PPCO) today...
Penwest First Quarter 2010 Financial Results Conference Call
26. April 2010 16:15 ET
|
Penwest Pharmaceuticals Co.
PATTERSON, N.Y., April 26, 2010 (GLOBE NEWSWIRE) -- Penwest Pharmaceuticals Co. (Nasdaq:PPCO) will conduct a conference call on Monday, May 3, at 10:00 a.m. EDT to review its financial results for the...
Penwest Provides Update on Recent Business Progress and Corporate Governance Developments
23. April 2010 09:00 ET
|
Penwest Pharmaceuticals Co.
Company Successfully Executing Focused Business Plan; Delivering Profitability and Gains in Shareholder Value
Anticipates Proxy Contest in Connection with June 22 Annual Meeting
PATTERSON,...
Penwest and Endo Enter Into Agreement With Barr to Settle Patent Litigation Over Opana(R) ER
13. April 2010 08:30 ET
|
Penwest Pharmaceuticals Co.
PATTERSON, N.Y., April 13, 2010 (GLOBE NEWSWIRE) -- Penwest Pharmaceuticals (Nasdaq:PPCO) and Endo Pharmaceuticals (Nasdaq:ENDP) announced today that the companies have settled litigation with Barr...
Penwest Signs Multi-Drug Generics Agreement With Alvogen, Inc.
09. April 2010 08:30 ET
|
Penwest Pharmaceuticals Co.
PATTERSON, N.Y., April 9, 2010 (GLOBE NEWSWIRE) -- Penwest Pharmaceuticals Co. (Nasdaq:PPCO) today announced that it has signed a drug development and commercialization agreement with Alvogen, Inc....
Penwest Reports Fourth Quarter and Year End 2009 Financial Results
04. März 2010 08:00 ET
|
Penwest Pharmaceuticals Co.
Posts Second Consecutive Profitable Quarter
Outlines Guidance and Business Plan Goals for 2010
Announces Intent to Pay Special Cash Dividend in Fourth Quarter 2010
PATTERSON, N.Y., March 4,...
Penwest to Present at Cowen & Company 30th Annual Healthcare Conference
03. März 2010 10:00 ET
|
Penwest Pharmaceuticals Co.
PATTERSON, N.Y., March 3, 2010 (GLOBE NEWSWIRE) -- Penwest Pharmaceuticals Co. (Nasdaq:PPCO) today announced that Jennifer Good, President and Chief Executive Officer of Penwest, will be presenting at...